tofidence
Generic: tocilizumab
Labeler: biogen ma incDrug Facts
Product Profile
Brand Name
tofidence
Generic Name
tocilizumab
Labeler
biogen ma inc
Dosage Form
INJECTION
Routes
Active Ingredients
tocilizumab 20 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
64406-023
Product ID
64406-023_2edc5db5-3ecd-451e-bbdd-01fe8db1100b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761354
Marketing Start
2024-05-01
Marketing End
2027-08-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
64406023
Hyphenated Format
64406-023
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tofidence (source: ndc)
Generic Name
tocilizumab (source: ndc)
Application Number
BLA761354 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/mL
Packaging
- 1 VIAL, SINGLE-USE in 1 CARTON (64406-023-01) / 10 mL in 1 VIAL, SINGLE-USE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2edc5db5-3ecd-451e-bbdd-01fe8db1100b", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["I031V2H011"], "rxcui": ["2680287", "2680294", "2680296", "2680297", "2680298", "2680299"], "spl_set_id": ["00529b23-850a-42b9-a152-125a95b5242c"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["Biogen MA Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (64406-023-01) / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "64406-023-01", "marketing_end_date": "20270801", "marketing_start_date": "20240501"}], "brand_name": "Tofidence", "product_id": "64406-023_2edc5db5-3ecd-451e-bbdd-01fe8db1100b", "dosage_form": "INJECTION", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "64406-023", "generic_name": "Tocilizumab", "labeler_name": "Biogen MA Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tofidence", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "20 mg/mL"}], "application_number": "BLA761354", "marketing_category": "BLA", "marketing_end_date": "20270801", "marketing_start_date": "20240501"}